Skip to main content

Table 1 Frequency (%) and absolute numbers (cells/ μL) of peripheral blood monocyte subsets in cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC) patients, both at the time of surgical procedure (T0) and once the patients were recovered from surgery (T1), and in healthy individuals (HG). Frequencies of monocyte subsets are related to the total of monocytes

From: Elevated soluble TNFα levels and upregulated TNFα mRNA expression in purified peripheral blood monocyte subsets associated with high-grade hepatocellular carcinoma

 CCA
N = 8
HCC
N = 20
HG
N = 10
T0T1T0T1
% Monocytes (in whole blood)2,4 (1,0-6,6)a,b4,9 (2,2-7,0)a4,2 (1,5–10)a,b5,5 (2,7-9,5)a8,2 (5,7–12)
Monocytes/μL141 (51–330)a219 (128–306)a329 (135–850)a353 (127–733)503 (285–757)
 % Classical89 (76–98)84 (75–92)89 (41–97)a90 (74–96)a83 (70–88)
 Classical monocytes/μL139 (40–287)a,b161 (111–282)a318 (129–1361)c264 (102–601)393 (171–651)
 % Intermediate4,4 (0,3–14)7,3 (4,8–12)2,5 (0,5–42)4,8 (1,7–13)5,5 (2,8-8,2)
 Intermediate monocytes/μL6,1 (0,4–36)a15 (8,3–17)a12 (0,8–194)13 (5,8–79)23 (17–51)
  % HLADR+ Intermediate32 (23–83)44 (33–63)45 (16–72)a38 (23–80)33 (13–56)
  % HLADR++ Intermediate68 (17–77)56 (37–67)55 (28–84)a62 (20–77)68 (44–87)
 % Non-Classical6,0 (0,4-7,5)a5,0 (1,1–14)3,6 (1,0–22)a3,5 (0,9–13)a11 (5,2–28)
 Non-classical monocytes/μL6,7 (0,6–24)a6,5 (1,4–24)a15 (2,4–60)a13 (2,6–58)a61 (26–84)
  1. Independent-samples Mann-Whitney U test was performed to compare: each group of patients vs healthy group (a); CCA vs HCC (b), The Wilcoxon test was performed to compare T1 vs T0 (c), all of them with a significance level of 0.05 (p < 0.05). The results are given by median (minimum value-maximum value)